Agilent Technologies Operating Profit Margin Over Time
| A Stock | USD 137.97 0.17 0.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Agilent Technologies Performance and Agilent Technologies Correlation. Agilent |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.569 | Earnings Share 4.43 | Revenue Per Share 22.269 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0758 |
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilent Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Profit Margin Analysis
Compare Agilent Technologies and related stocks such as Verve Therapeutics, Beam Therapeutics, and Caribou Biosciences Operating Profit Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VERV | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (85.3617) | (18.9764) | (19.93) |
| BEAM | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (4.2 K) | (5.5 K) | (7.5701) | (5.5561) | (0.4673) | (0.49) |
| CRBU | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (5.9269) | (2.9224) | (6.9784) | (7.6817) | (3.3663) | (3.53) |
| SANA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RPRX | 0.4807 | 0.4807 | 0.4807 | 0.4807 | 0.4807 | 0.4807 | 0.385 | 0.5881 | 0.7602 | 1.4459 | 0.7516 | 0.6249 | 0.4369 | 0.6337 | 0.54 |
| IKNA | (41.3071) | (41.3071) | (41.3071) | (41.3071) | (41.3071) | (41.3071) | (41.3071) | (41.3071) | (41.3071) | (1.3446) | (4.8422) | (1.1018) | (4.5399) | (8.2333) | (8.64) |
| HEPA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| KRYS | (11.6027) | (11.6027) | (11.6027) | (11.6027) | (11.6027) | (11.6027) | (11.6027) | (11.6027) | (11.6027) | (2.1643) | (2.1643) | (2.1643) | (2.1643) | (1.95) | (2.05) |
| ENVB | (5.5) | (0.1171) | (0.1171) | (0.1171) | (0.1171) | (0.1171) | (0.1488) | (0.2463) | (0.1662) | (0.1585) | (0.1585) | (0.1585) | (0.1585) | (0.14) | (0.15) |
| ELEV | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Agilent Technologies and related stocks such as Verve Therapeutics, Beam Therapeutics, and Caribou Biosciences Operating Profit Margin description
My Equities
My Current Equities and Potential Positions
| Agilent Technologies | A |
| Classification | Measuring and Control Equipment |
| Location | California; U.S.A |
| Exchange | New York Stock Exchange |
USD 137.97
Check out Agilent Technologies Performance and Agilent Technologies Correlation. For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Agilent Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.